Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations.
作者信息
Damlaj Moussab, Al Balwi Mohammed, Al Mugairi Areej M
机构信息
a Division of Hematology & HSCT, Department of Oncology , King Abdul-Aziz Medical City , Riyadh , KSA.
b King Abdullah International Medical Research Center , Riyadh , KSA.
出版信息
Leuk Lymphoma. 2018 Mar;59(3):739-742. doi: 10.1080/10428194.2017.1347653. Epub 2017 Jul 11.
Abstract
摘要
Zotero 插件